For immediate release: 04 January 2016
HALO X-ray Technologies expands into MediCity
HALO X-ray Technologies (HXT) has relocated to MediCity, the innovation hub on the Boots site in Beeston, Nottingham. Expansion plans have required the company to take new office space at MediCity in readiness for the recruitment of at least three new members of staff in early 2016.
HXT was formerly based on the Nottingham Trent University Clifton Campus, where specially-equipped facilities, combined with funding from a variety of sources, enabled the necessary prototype testing to prove the capability of the technology. HXT will continue to work with research teams at Nottingham Trent University and Cranfield University as part of on-going plans to develop commercial products.
Dr. Simon Godber, HXT Director and Chief Executive Officer is heading-up the expansion into MediCity and is especially keen to draw on the incubator’s global connections in the medical device and healthcare sectors.
“MediCity is an ideal base for the next stage of our development. We have benefitted greatly from the excellent research facilities at Nottingham Trent University as well as their invaluable advice and financial support in the pre-start-up and early commercial phases. Now we are ready to expand and experience the risks and rewards of growing this venture. Given the close working relationship between MediCity and NTU, we hope to benefit from both organisations’ expertise.”
Notes for Editors
HALO X-ray Technologies has been spun out of the Imaging Science Group at Nottingham Trent University and the Cranfield Forensic Institute at Cranfield University.
HXT is pioneering the development of advanced, real-time, X-ray diffraction techniques and systems in aviation security, medical systems and industrial process control.
Simon Godber, CEO, HALO X-ray Technologies Ltd.
Phone: 0115 860 2236